Federal funding cuts are disrupting pediatric brain cancer research in 2026, delaying progress on treatments for a rare childhood disease.

China to launch 2026 pilot cloud system merging health, insurance data for personalized care and AI use.

Curiteva launched its new spinal implant system in January 2026, marking a major step in anterior spine surgery innovation.

Anondita Medicare gained MDSAP certification, enabling global sales of its medical devices.

Rhythm Biosciences launched a new gene-based test to better predict colorectal cancer risk and boost early detection.

Ipsen shared new data on neurological treatments at TOXINS 2026, advancing care for conditions like dystonia.

AJOVY, a migraine drug, significantly reduced headaches in kids and teens, and is now FDA-approved for those 6–17.

MediCapture launches AI-powered imaging tool aiScope™ at VMX 2026 for veterinary diagnostics.

U.S. cancer survival rates hit a record 70%, driven by early detection, better treatments, and reduced smoking.

The FDA released AI drug development guidelines, with one AI-designed drug now in clinical trials.